Mechanism For Potential Friedreich's Ataxia Drug Uncovered
Medical News Today
28 September 2009
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
28 September 2009
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Latest news:
20th July 2011 -
ALZHEIMER’S ASSOCIATION WELCOMES PRESIDENT NICOLAS SARKOZY TO INTERNATIONAL CONFERENCE
20th July 2011 -
LATE BREAKING RESEARCH RESULTS FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2011
20th July 2011 -
INTERNATIONAL STUDY OF GENETIC ALZHEIMER’S DISEASE GIVES CLUES TO PRESYMPTOMATIC DETECTION AND PROGRESSION OF THE DISEASE
19th July 2011 -
NEW GLOBAL MODEL OF ALZHEIMER’S RISK SUGGESTS A 25 PERCENT REDUCTION IN PRESUMED RISK FACTORS COULD LOWER ALZHEIMER’SCASES BY 3 MILLION WORLDWIDE
18th July 2011 -
BRAIN INJURY MAY MORE THAN DOUBLE DEMENTIA RISK IN OLDER VETERANS
18th July 2011 -
Women at the Center of the Global Alzheimer’s Epidemic
